Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $256312.0.

  • Iradimed's Depreciation and Depletion rose 8328.95% to $256312.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $661685.0, marking a year-over-year increase of 772.54%. This contributed to the annual value of $585542.0 for FY2024, which is 965.71% down from last year.
  • According to the latest figures from Q3 2025, Iradimed's Depreciation and Depletion is $256312.0, which was up 8328.95% from $135670.0 recorded in Q2 2025.
  • In the past 5 years, Iradimed's Depreciation and Depletion ranged from a high of $256312.0 in Q3 2025 and a low of $127139.0 during Q1 2021
  • For the 5-year period, Iradimed's Depreciation and Depletion averaged around $150619.6, with its median value being $141697.0 (2024).
  • Over the last 5 years, Iradimed's Depreciation and Depletion had its largest YoY gain of 8328.95% in 2025, and its largest YoY loss of 2033.83% in 2025.
  • Quarter analysis of 5 years shows Iradimed's Depreciation and Depletion stood at $135997.0 in 2021, then grew by 9.99% to $149581.0 in 2022, then grew by 9.67% to $164039.0 in 2023, then decreased by 17.49% to $135348.0 in 2024, then soared by 89.37% to $256312.0 in 2025.
  • Its Depreciation and Depletion stands at $256312.0 for Q3 2025, versus $135670.0 for Q2 2025 and $134355.0 for Q1 2025.